Canopy Growth (CGC) Restructuring Costs (2020 - 2023)
Canopy Growth (CGC) reported Restructuring Costs of $1.6 million for Q2 2023, down 99.88% on a YoY basis from $1.4 billion in Q2 2022, and up 100.12% sequentially from -$1.4 billion in Q1 2023.
Canopy Growth (CGC) Restructuring Costs (2020 - 2023) Analysis & Trends
Canopy Growth (CGC) has 4 years of Restructuring Costs data on file, last reported at $1.6 million in Q2 2023.
- For the quarter ending Q2 2023, Restructuring Costs fell 99.88% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2023 stood at -$1.3 billion (down 184.87% YoY), and the FY2026 full-year result was $48.9 million, up 124.72% from the prior year.
- Restructuring Costs rose to $1.6 million in Q2 2023, from -$1.4 billion in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.4 billion in Q2 2022 to a low of -$1.4 billion in Q1 2023.
- A 4-year average of $55.5 million and a median of $28.9 million in 2021 frame the typical range for Restructuring Costs.
- Across the five-year window, Restructuring Costs surged 1763.85% in 2022 and plunged 812.53% in 2023, its largest moves.
- Tracing CGC's Restructuring Costs over 4 years: stood at $307.1 million in 2020, then plunged by 90.59% to $28.9 million in 2021, then plunged by 43.28% to $16.4 million in 2022, then plunged by 90.19% to $1.6 million in 2023.
- Business Quant data shows CGC's Restructuring Costs at $1.6 million in Q2 2023, -$1.4 billion in Q1 2023, and $16.4 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | -1.36 Bn |
| Dec 31, 2022 | 16.40 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.35 Bn |
| Mar 31, 2022 | 190.31 Mn |
| Dec 31, 2021 | 28.91 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 72.61 Mn |
| Mar 31, 2021 | 59.11 Mn |
| Dec 31, 2020 | 307.15 Mn |
| Sep 30, 2020 | 34.79 Mn |
| Jun 30, 2020 | 9.23 Mn |